Evidence map›Paper›PMID 31715032›Full record

ArticleRapid communications in mass spectrometry : RCM2020

A novel caged Cookson-type reagent toward a practical vitamin D derivatization method for mass spectrometric analyses.

Masahiko Seki, Makoto Sato, Masaki Takiwaki, Koji Takahashi, Yoshikuni Kikutani, Mamoru Satoh, Fumio Nomura, Yutaka Kuroda, Seketsu Fukuzawa

Open access · hybridAbstract read
In one paragraph

Article in Rapid communications in mass spectrometry : RCM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Masahiko SekiMedical Association Group, Tokuyama Corporation, Ibaraki, Japan.
Makoto SatoTsukuba Research Lab, Tokuyama Corporation, Ibaraki, Japan.
Masaki TakiwakiOpen Innovation Promotion Department, Management Strategy Planning Division, JEOL Ltd., Tokyo, Japan.
Koji TakahashiOpen Innovation Promotion Department, Management Strategy Planning Division, JEOL Ltd., Tokyo, Japan.
Yoshikuni KikutaniOpen Innovation Promotion Department, Management Strategy Planning Division, JEOL Ltd., Tokyo, Japan.
Mamoru SatohDivision of Clinical Mass Spectrometry, Chiba University Hospital, Chiba, Japan.
Fumio NomuraDivision of Clinical Mass Spectrometry, Chiba University Hospital, Chiba, Japan.
Yutaka KurodaDepartment of Biotechnology and Life Science, Faculty of Technology, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Seketsu FukuzawaOpen Innovation Promotion Department, Management Strategy Planning Division, JEOL Ltd., Tokyo, Japan.ORCID https://orcid.org/0000-0002-1978-4664
JEOL (Japan) · JPChiba University Hospital · JPTokuyama (Japan) · JPTokyo University of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationale25-Hydroxylated vitamin D is the best marker for vitamin D (VD). Due to its low ionization efficiency, a Cookson-type reagent, 1,2,4-triazoline-3,5-dione (TAD), is used to improve the detection/quantification of VD metabolites by liquid chromatography/tandem mass spectrometry (LC/MS/MS). However, the high reactivity of TAD makes its solution stability low and inconvenient for practical use. We here describe the development of a novel caged Cookson-type reagent, and we assess its performances in the quantitative and differential detection of four VD metabolites in serum using LC/MS/MS.

methodsCaged 4-(4'-dimethylaminophenyl)-1,2,4-triazoline-3,5-dione (DAPTAD) analogues were prepared from 4-(4'-dimethylaminophenyl)-1,2,4-triazolidine-3,5-dione. Their stability and reactivity were examined. The optimized caged DAPTAD (14-(4-(dimethylamino)phenyl)-9-phenyl-9,10-dihydro-9,10-[1,2]epitriazoloanthracene-13,15-dione, DAP-PA) was used for LC/MS/MS analyses of VD metabolites.

resultsThe solution stability of DAP-PA in ethyl acetate dramatically improved compared with that of the non-caged one. We measured the thermal retro-Diels-Alder reaction enabling the release of DAPTAD and found that the derivatization reaction was temperature-dependent. We also determined the detection limit and the lower limit of quantifications for four VD metabolites with DAPTAD derivatization.

conclusionsDAP-PA was stable enough for mid- to long-term storage in solution. This advantage shall contribute to the detection and quantification of VD in clinical laboratories, and as such to the broader use of clinical mass spectrometry.

Indexed as

25-Hydroxyvitamin D 2Aniline CompoundsCalcifediolChromatography, LiquidHumansIndicators and ReagentsLimit of DetectionTandem Mass SpectrometryTriazolesVitamin D25-Hydroxyvitamin D 24-(4-dimethylaminophenyl)-1,2,4-triazoline-3,5-dioneAniline CompoundsCalcifediolIndicators and ReagentsTriazolesVitamin Dclinical laboratoryCooksonderivatizationmass spectrometryvitamin D

Identifiers

PMID31715032
PMCPMC7064983
OpenAlexW2986367297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.